【摘要】 目的 :探讨绝经后妇女骨质疏松的治疗方法。方法 :将 86例绝经后骨质疏松患者随机分成 A组 (实验组 ,口服利维爱加钙尔奇 - D片 )、B组 (对照组 ,单服钙尔奇 - D片 ) ,比较两组的更年期症状与骨密度 (BMD)、血清降钙素 (h-CT)、血清骨钙素 (BGP)和甲状旁腺素 (PTH)等指标的变化情况。结果 :A组的临床有效率为 79.0 7% ,明显高于对照组(5 8.14 % ,P<0 .0 5 )。A组 BMD明显增加 (P<0 .0 5 ) ,BGP、h- CT水平显著增高 (P<0 .0 1) ,PTH水平显著降低 (P<0 .0 5 )结论 :口服利维爱加钙尔奇 - D片 ,是治疗绝经后妇女骨质疏松较好的方法更多还原

【Abstract】 Objectives:To view the curative effect of estrogen replacement therapy(ERT) in postmenopausal osteoporosis.Methods: 86 cases of postmenopausal osteoporosis were divided into experimental group(given oral Livial and Caltrated D)and control group(given oral Caltrated D).The clinically effective rates and bone metabolite indexes including bone mass density(BMD),bone glaconfaining protein(BGP),calcitonin(CT)and parathormone(PTH)were measured.Results: The clinically effective rate in experimental group was 79.07%,its significantly higher than that in control group(58.14%, P < 0.05 ).The levels of BMD,BGP,CT were increased significantly( P <0.05, P <0.01),and PTH was decreased significantly( P <0.05)in erperimental group than that in control group. Conclusions: It was suggested that ERT was one of an effectively therapeutic method for postmenopausal osteoporosis.更多还原